Author:
Zhang Yunliang,Lin Xiaoyan,Bush Karen
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference35 articles.
1. Centers for Disease Control and Prevention Antibiotic Resistance Threats in the United States, United States Department of Health and Human Services, Atlanta, GA, USA, (2013).
2. Drekonja, D. M. et al. Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae. Infect. Control Hosp. Epidemiol. 35, 437–439 (2014).
3. Satlin, M. J., Jenkins, S. G. & Walsh, T. J. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin. Infect. Dis. 58, 1274–1283 (2014).
4. Bassetti, M. & Righi, E. New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections. Curr. Opin. Crit. Care 21, 402–411 (2015).
5. Bush, K. Investigational agents for the treatment of Gram-negative bacterial infections: a reality check. ACS Infect. Dis. 1, 509–511 (2015).
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献